Publications by authors named "Connie Marras"

99Publications

Using artificial intelligence to identify anti-hypertensives as possible disease modifying agents in Parkinson's disease.

Pharmacoepidemiol Drug Saf 2020 Nov 20. Epub 2020 Nov 20.

Edmond J. Safra program in Parkinson's disease and the Morton and Gloria Shulman Movement disorders clinic, Toronto Western Hospital, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pds.5176DOI Listing
November 2020

Variations in hospitalization rates across Parkinson's Foundation Centers of Excellence.

Parkinsonism Relat Disord 2020 Oct 3;81:123-128. Epub 2020 Oct 3.

Edmond J. Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital and the University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2020.09.006DOI Listing
October 2020

Reply to Comment on: The Most Bothersome Aspects of off Periods Reported by Individuals with Parkinson's Disease.

Mov Disord Clin Pract 2020 Oct 16;7(7):879-880. Epub 2020 Aug 16.

Department of Neurology University of Toronto Toronto Ontario Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mdc3.13021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533975PMC
October 2020

Cognitive impairment in Parkinson's disease: Associations between subjective and objective cognitive decline in a large longitudinal study.

Parkinsonism Relat Disord 2020 Sep 20;80:127-132. Epub 2020 Sep 20.

Edmond J Safra Program in Parkinson's Disease, Toronto Western Hospital, UHN, Division of Neurology, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2020.09.028DOI Listing
September 2020

The Impact of COVID-19 on Access to Parkinson's Disease Medication.

Mov Disord 2020 Aug 28. Epub 2020 Aug 28.

Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.28293DOI Listing
August 2020

Therapy of Parkinson's Disease Subtypes.

Neurotherapeutics 2020 Aug 4. Epub 2020 Aug 4.

The Ottawa Hospital Research Institute and University of Ottawa Brain and Mind Research Institute, Ottawa, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13311-020-00894-7DOI Listing
August 2020

Parkinson disease with mild cognitive impairment: Domain-specific cognitive complaints predict dementia.

Acta Neurol Scand 2020 Aug 1. Epub 2020 Aug 1.

The Morton Shulman Movement Disorders Centre and the Edmond J Safra Program in Parkinson's Disease, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ane.13326DOI Listing
August 2020

Clinical Follow-up of Parkinson's Disease With Newly Prescribed Quetiapine.

Mov Disord 2020 Jul 29. Epub 2020 Jul 29.

Department of Veterans Affairs, HSR&D Center for Clinical Management Research (CCMR), Ann Arbor, Michigan, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.28193DOI Listing
July 2020

Survival in Restless Legs Syndrome: An 11-Year Surveillance, Community-Based Population Study.

Neuroepidemiology 2020 20;54(5):375-382. Epub 2020 Jul 20.

Toronto Western Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000508855DOI Listing
July 2020

Huntington's Disease and Hypertension: Sorting Out Mixed Messages.

Mov Disord 2020 06;35(6):915-917

Department of Biostatistics and Computational Biology, University of Rochester, Rochester, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.28076DOI Listing
June 2020

Beta Agonists and Progression of Parkinson's Disease in Older Adults: A Retrospective Cohort Study.

Mov Disord 2020 07 15;35(7):1275-1277. Epub 2020 May 15.

The Edmond J Safra Program in Parkinson's disease, University Health Network, University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.28085DOI Listing
July 2020

Identifying drugs with disease-modifying potential in Parkinson's disease using artificial intelligence and pharmacoepidemiology.

Pharmacoepidemiol Drug Saf 2020 08 14;29(8):864-872. Epub 2020 May 14.

ICES, Life Stage Research Program, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pds.5015DOI Listing
August 2020

Age-Related Parkinsonian Signs in Microdeletion 22q11.2.

Mov Disord 2020 07 9;35(7):1239-1245. Epub 2020 May 9.

The Dalglish Family 22q Clinic, University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.28080DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497092PMC
July 2020

Disparities in Deep Brain Stimulation Use for Parkinson's Disease in Ontario, Canada.

Can J Neurol Sci 2020 Sep 24;47(5):642-655. Epub 2020 Apr 24.

Department of Psychiatry, Queen's University, ICES-Queen's, Kingston, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/cjn.2020.79DOI Listing
September 2020

Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation.

J Vis Exp 2020 03 21(157). Epub 2020 Mar 21.

MRC Protein Phosphorylation and Ubiquitylation Unit, School of Life Sciences, University of Dundee; Division of Molecular and Clinical Medicine, School of Medicine, Ninewells Hospital and Medical School, University of Dundee;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3791/58956DOI Listing
March 2020

Progressive Supranuclear Palsy and Statin Use.

Mov Disord 2020 07 27;35(7):1253-1257. Epub 2020 Mar 27.

Movement Disorders Center, Department of Neurosciences, University of California San Diego, San Diego, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.28038DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375943PMC
July 2020

Experience and Impact of OFF Periods in Parkinson's Disease: A Survey of Physicians, Patients, and Carepartners.

J Parkinsons Dis 2020 ;10(1):315-324

The Morton and Gloria Shulman Movement Disorders Centre and the Edmond J Safra Program in Parkinson's Research, Toronto Western Hospital, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/JPD-191785DOI Listing
January 2020

Understanding the links between cardiovascular disease and Parkinson's disease.

Mov Disord 2020 01 4;35(1):55-74. Epub 2019 Sep 4.

The Edmond J Safra Program in Parkinson's Research, Toronto Western Hospital, University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.27836DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6981000PMC
January 2020

Communication About OFF Periods in Parkinson's Disease: A Survey of Physicians, Patients, and Carepartners.

Front Neurol 2019 19;10:892. Epub 2019 Aug 19.

The Morton and Gloria Shulman Movement Disorders Centre and the Edmond J. Safra Program in Parkinson's Research, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fneur.2019.00892DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709650PMC
August 2019

Increased markers of cardiac vagal activity in leucine-rich repeat kinase 2-associated Parkinson's disease.

Clin Auton Res 2019 12 23;29(6):603-614. Epub 2019 Aug 23.

Facultad de Biología, Universidad de La Habana, Calle 25 No. 455, Vedado, Plaza de la Revolución, 10400, La Habana, Cuba.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10286-019-00632-wDOI Listing
December 2019

Recent developments in drug-induced movement disorders: a mixed picture.

Lancet Neurol 2019 09 3;18(9):880-890. Epub 2019 Jul 3.

Department of Neurological Sciences, Rush Medical College, Chicago, IL, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S14744422193015
Publisher Site
http://dx.doi.org/10.1016/S1474-4422(19)30152-8DOI Listing
September 2019

Environment, lifestyle, and Parkinson's disease: Implications for prevention in the next decade.

Mov Disord 2019 06 15;34(6):801-811. Epub 2019 May 15.

School of Medicine, University of California-San Francisco, San Francisco, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.27720DOI Listing
June 2019

Reply to 'Neuropathological progression of clinical Parkinson disease subtypes'.

Nat Rev Neurol 2019 06;15(6):361-362

Morton and Gloria Shulman Movement Disorders Centre and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital, University of Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41582-019-0198-9DOI Listing
June 2019

Barriers and facilitators of communication about off periods in Parkinson's disease: Qualitative analysis of patient, carepartner, and physician Interviews.

PLoS One 2019 18;14(4):e0215384. Epub 2019 Apr 18.

Morton and Gloria Shulman Movement Disorders Centre and the Edmond J Safra Program in Parkinson's Research, Toronto Western Hospital, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0215384PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472878PMC
January 2020

Cognitive Complaints in Nondemented Parkinson's Disease Patients and Their Close Contacts do not Predict Worse Cognitive Outcome.

Alzheimer Dis Assoc Disord 2019 Apr-Jun;33(2):147-153

Division of Neurology, Morton and Gloria Shulman Movement Disorders Center and the Edmond J Safra Program in Parkinson's disease, Toronto Western Hospital, University of Toronto.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WAD.0000000000000301DOI Listing
April 2020

Clinical Parkinson disease subtyping does not predict pathology.

Nat Rev Neurol 2019 04;15(4):189-190

Morton and Gloria Shulman Movement Disorders Centre and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41582-019-0153-9DOI Listing
April 2019

Concordance for Parkinson's disease in twins: A 20-year update.

Ann Neurol 2019 04 11;85(4):600-605. Epub 2019 Mar 11.

Department of Neurology; University of California-San Francisco, San Francisco Veterans Affairs Health Care System, University of California-San Francisco, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ana.25441DOI Listing
April 2019

22q11.2 Deletion Syndrome-Associated Parkinson's Disease.

Mov Disord Clin Pract 2019 Jan 9;6(1):11-16. Epub 2018 Nov 9.

Morton and Gloria Shulman Movement Disorders Centre and the Edmond J. Safra Program in Parkinson's Disease Research Toronto Western Hospital and University of Toronto Toronto Ontario Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mdc3.12687DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335527PMC
January 2019

Reply to "Studying reproducibility of data-driven Parkinson's disease subtypes".

Parkinsonism Relat Disord 2019 09 28;66:245-246. Epub 2018 Dec 28.

Morton and Gloria Shulman Movement Disorders Center and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital, University of Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2018.12.028DOI Listing
September 2019

We are what we eat - editors' note on the role of diet in Parkinson's disease.

Mov Disord 2019 01;34(1)

CINAC (Centro Integral de Neurociencias), University Hospital HM Puerta del Sur, CEU-San Pablo University, Móstoles, and CIBERNED, Instituto Carlos III, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.27613DOI Listing
January 2019

Risk of Parkinson's disease dementia related to level I MDS PD-MCI.

Mov Disord 2019 03 17;34(3):430-435. Epub 2019 Jan 17.

Department of Medical Psychology, Academic Medical Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.27617DOI Listing
March 2019

MDSGene: Closing Data Gaps in Genotype-Phenotype Correlations of Monogenic Parkinson's Disease.

J Parkinsons Dis 2018 ;8(s1):S25-S30

Department of Neurology, Juntendo University, Bunkyo, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/JPD-181505DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311364PMC
October 2019

Understanding, Impact, and Communication of "Off" Periods in Parkinson's Disease: A Scoping Review.

Mov Disord Clin Pract 2018 Sep-Oct;5(5):461-470. Epub 2018 Oct 9.

Morton and Gloria Shulman Movement Disorders Centre and the Edmond J Safra Program in Parkinson's Research Toronto Western Hospital Toronto ON Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mdc3.12672DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207105PMC
October 2018

Educational Needs and Considerations for a Visual Educational Tool to Discuss Parkinson's Disease.

Mov Disord Clin Pract 2018 Jan-Feb;5(1):66-74. Epub 2017 Nov 27.

Division of Neurology Department of Medicine University of Toronto Toronto Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mdc3.12563DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174478PMC
November 2017

Genotype-phenotype relations for the Parkinson's disease genes SNCA, LRRK2, VPS35: MDSGene systematic review.

Mov Disord 2018 12 24;33(12):1857-1870. Epub 2018 Oct 24.

The Morton and Gloria Shulman Movement Disorders Centre and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.27527DOI Listing
December 2018

Antipsychotic Drug Dispensing in Older Adults With Parkinsonism.

Am J Geriatr Psychiatry 2018 12 3;26(12):1244-1257. Epub 2018 Sep 3.

the Institute for Clinical Evaluative Sciences (PCA, SEB, CD, PAR), Toronto; Women's College Hospital Research Institute (SEB, PAR), Women's College Hospital, Toronto.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jagp.2018.08.003DOI Listing
December 2018

Investigating Voice as a Biomarker for Leucine-Rich Repeat Kinase 2-Associated Parkinson's Disease.

J Parkinsons Dis 2018 ;8(4):503-510

The Edmond J. Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Centre and, Toronto Western Hospital, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/JPD-181389DOI Listing
October 2019

Brain tissue pulsatility is related to clinical features of Parkinson's disease.

Neuroimage Clin 2018 23;20:222-227. Epub 2018 Jul 23.

Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada; Hurvitz Brain Sciences Research Program, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nicl.2018.07.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079564PMC
January 2019

Reproducibility of data-driven Parkinson's disease subtypes for clinical research.

Parkinsonism Relat Disord 2018 11 20;56:102-106. Epub 2018 Jul 20.

Morton and Gloria Shulman Movement Disorders Centre and the Edmond J Safra Program in Parkinson's Disease, Toronto Western Hospital, University of Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2018.07.009DOI Listing
November 2018

The genetic nomenclature of recessive cerebellar ataxias.

Mov Disord 2018 07 14;33(7):1056-1076. Epub 2018 May 14.

Department of Neurology, Donders Institute for Brain, Cognition & Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.27415DOI Listing
July 2018

Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2.

Neurology 2018 06 11;90(23):e2059-e2067. Epub 2018 May 11.

From The Dalglish Family 22q Clinic for Adults and Department of Psychiatry (E.B., A.M.F., A.S.B.), Toronto General Research Institute (A.S.B.), and Division of Cardiology, Department of Medicine (A.S.B.), University Health Network, Toronto, Canada; De Hartekamp Groep (E.B.), Centre for People with Intellectual Disability, Haarlem; Department of Nuclear Medicine (E.B., J.B.), Academic Medical Center, Amsterdam, the Netherlands; Clinical Genetics Research Program and Campbell Family Mental Health Research Institute (N.J.B., A.M.F., A.S.B.), Centre for Addiction and Mental Health, Toronto; Institute of Medical Science (N.J.B., M.M., A.E.L., A.S.B.), Division of Neurology, Department of Medicine (C.M., M.M., A.E.L.), and Department of Psychiatry (A.S.B.), University of Toronto; Deer Lodge Movement Disorders Centre (S.U.); Section of Neurology (S.U.), Division of Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg; Morton and Gloria Shulman Movement Disorders Centre and the Edmond J. Safra Program in Parkinson's Disease Research (C.M., A.E.L.), Toronto Western Hospital and University of Toronto, Canada; Department of Molecular Neuroscience (K.Y.M., N.W.W.), UCL Institute of Neurology, London, UK; Department of Neurology (S.K.), Kansai Medical University, Osaka, Japan; Department of Neurology (M.J.B.), University of Virginia School of Medicine, Charlottesville; Medical Genetics Unit (P.P.), Perugia University Hospital, Italy; Department of Neurology (B.D.B.), University of Colorado Anschutz Medical Campus, Aurora; Neurology Section (B.D.B.), VA Eastern Colorado Health Care System, Denver; Cognitive & Movement Disorders Clinic and Hurvitz Brain Sciences Research Program (M.M.), Sunnybrook Health Sciences Centre, Toronto, Canada; Departments of Clinical Neurosciences (Movement Disorders) (B.D.) and Genetics (Neurogenetics) (K.N.), Timone University Hospital (AP-HM), Provence-Alpes-Côte d'Azur; Aix-Marseille University (B.D., K.N.), Marseille; Department of Genetics (Neurogenetics) (P.C., A.J.), Pitié-Salpêtrière University Hospital; Sorbonne University (P.C., A.J.), Paris; Department of Neurosciences (Movement Disorders) (E.M.), Lille University Hospital; Lille University (E.M.); Department of Neurology (Movement Disorders) (T.D.), Pierre Wertheimer University Hospital, Lyon; Marc Jeannerod Center for Cognitive Neurosciences (T.D.), Lyon-1 University; Department of Neurology (Movement Disorders) and Clinical Investigation Center (Clinical and Experimental Neurosciences) (O.C.), Poitiers University Hospital; Department of Neurology (Movement Disorders) (S.D.), Rennes University Hospital; Rennes-1 University (S.D.); Department of Clinical Neurosciences (Movement Disorders) (M.B.), Nice University Hospital, France; Department of Psychiatry (A.M.F.), Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, the Netherlands; Center for Human Genetics (E.V., A.S., A.V.), University Hospital Leuven; Department of Human Genetics (A.S.), KU Leuven, Belgium; Department of Neurology (A.P.), University of Munich, Germany; Scientific and Technological Coordination Unit of the ANLIS Directorate (C.P.), National Administration of Laboratories and Institutes of Health, Argentina; Department of Neurodegenerative Diseases (T.G.), Center of Neurology and Hertie-Institute for Clinical Brain Research, University of Tübingen; German Center for Neurodegenerative Diseases (DZNE) (T.G.); Department of Neurology (K.C.), AZ Turnhout, Antwerp, Belgium; Neurology Unit and Stroke Center (F.B.), Hôpital Foch, Suresnes, France; Movement Disorder Division (K.M.), Johns Hopkins University, Baltimore, MD; and Psychological Medicine and Clinical Neurosciences (N.M.W.), MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University School of Medicine, Cardiff University, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000005660DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993183PMC
June 2018

Emotion Detection Deficits and Decreased Empathy in Patients with Alzheimer's Disease and Parkinson's Disease Affect Caregiver Mood and Burden.

Front Aging Neurosci 2018 24;10:120. Epub 2018 Apr 24.

Division of Neurology, Krembil Neuroscience Centre, Toronto Western Hospital, University Health Network Memory Clinic, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fnagi.2018.00120DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928197PMC
April 2018

Risk factors for non-motor symptoms in Parkinson's disease.

Lancet Neurol 2018 06 23;17(6):559-568. Epub 2018 Apr 23.

Department of Neurology, Leiden University Medical Center, Leiden, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1474-4422(18)30127-3DOI Listing
June 2018

A 21-Year Retrospective Study of the Toronto Western Hospital Deep Brain Stimulation Cohort.

Mov Disord 2018 05 23;33(5):850-852. Epub 2018 Mar 23.

Morton and Gloria Shulman Movement Disorders Centre and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital, University Health Network (UHN), Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.27359DOI Listing
May 2018

Initial cognitive changes in Parkinson's disease.

Mov Disord 2018 04 15;33(4):511-519. Epub 2018 Mar 15.

Rush University Medical Center, Department of Neurological Sciences, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.27330DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920539PMC
April 2018

Actigraphy Detects Greater Intra-Individual Variability During Gait in Non-Manifesting LRRK2 Mutation Carriers.

J Parkinsons Dis 2018 ;8(1):131-139

Toronto Western Hospital Morton and Gloria Shulman Movement Disorders Centre and the Edmond J. Safra Program in Parkinson's Disease, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/JPD-171151DOI Listing
October 2019

Reply: MoCA for cognitive screening in Parkinson's disease: Beware of floor effect.

Mov Disord 2018 03 20;33(3):499-500. Epub 2018 Feb 20.

National Centre of Epidemiology and CIBERNED, Carlos III Institute of Health, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.27339DOI Listing
March 2018

Health and Community-Based Services for Individuals with Neurological Conditions.

Can J Neurol Sci 2017 11;44(6):670-675

8Department of Physical Therapy,Toronto Rehabilitation Institute,University of Toronto,Toronto,OntarioCanada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/cjn.2017.207DOI Listing
November 2017

Anti-inflammatory drug use and progressive supranuclear palsy.

Parkinsonism Relat Disord 2018 03 6;48:89-92. Epub 2017 Dec 6.

Movement Disorder Center, Department of Neurosciences, University of California San Diego, San Diego, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.parkreldis.2017.11.346DOI Listing
March 2018

Global scales for cognitive screening in Parkinson's disease: Critique and recommendations.

Mov Disord 2018 02 23;33(2):208-218. Epub 2017 Nov 23.

National Centre of Epidemiology and CIBERNED, Carlos III Institute of Health, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.27233DOI Listing
February 2018

Nonmotor Signs in Genetic Forms of Parkinson's Disease.

Int Rev Neurobiol 2017 13;133:129-178. Epub 2017 Jul 13.

Institute of Neurogenetics, University of Lübeck, Lübeck, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/bs.irn.2017.05.030DOI Listing
April 2018

Mild cognitive impairment as a risk factor for Parkinson's disease dementia.

Mov Disord 2017 Jul 12;32(7):1056-1065. Epub 2017 Jun 12.

Department of Medical Psychology, Academic Medical Center Amsterdam, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.27002DOI Listing
July 2017

Neuroimaging and clinical features in adults with a 22q11.2 deletion at risk of Parkinson's disease.

Brain 2017 May;140(5):1371-1383

Clinical Genetics Research Program and Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/brain/awx053DOI Listing
May 2017

What Would Dr. James Parkinson Think Today III: Measuring Health-Related Quality of Life.

Authors:
Connie Marras

Mov Disord 2017 03;32(3):364-365

Morton and Gloria Shulman Movement Disorders Centre and the Edmond J Safra Program in Parkinson's Disease, Toronto Western Hospital, University of Toronto, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.26983DOI Listing
March 2017

Antipsychotic Use and Physical Morbidity in Parkinson Disease.

Am J Geriatr Psychiatry 2017 Jul 2;25(7):697-705. Epub 2017 Feb 2.

Department of Veterans Affairs, HSR&D Center for Clinical Management Research, Ann Arbor, MI, USA; Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA; Geriatric Research, Education and Clinical Center, VA Ann Arbor Healthcare System, Ann Arbor, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jagp.2017.01.076DOI Listing
July 2017

The financial burden of prescription drugs for neurological conditions in Canada: Results from the National Population Health Study of Neurological Conditions.

Health Policy 2017 Apr 4;121(4):389-396. Epub 2017 Feb 4.

Toronto Rehabilitation Institute-University Health Network, 550 University Avenue, Toronto, Ontario M5G 2A2, Canada; Department of Physical Therapy, Faculty of Medicine, University of Toronto, 160-500 University Avenue, Toronto, ON M5G 1V7, Canada; Rehabilitation Sciences Institute, University of Toronto, 160-500 University Avenue, Toronto, ON M5G 1V7, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Health Sciences Building, 155 College Street, Suite 425, Toronto, Ontario, M5T 3M6, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.healthpol.2017.01.010DOI Listing
April 2017

Androgen deprivation therapy and the risk of parkinsonism in men with prostate cancer.

World J Urol 2017 Sep 15;35(9):1417-1423. Epub 2017 Feb 15.

Departments of Medicine, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-017-2010-zDOI Listing
September 2017

The Danger of Not Treating Parkinson Disease Psychosis-Reply.

JAMA Neurol 2016 09;73(9):1156-7

Morton and Gloria Shulman Movement Disorder Centre, The Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaneurol.2016.2274DOI Listing
September 2016

Appendectomy in mid and later life and risk of Parkinson's disease: A population-based study.

Mov Disord 2016 08 31;31(8):1243-7. Epub 2016 May 31.

The Institute for Clinical Evaluative Sciences and the University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.26670DOI Listing
August 2016

Launching the movement disorders society genetic mutation database (MDSGene).

Mov Disord 2016 05;31(5):607-9

Lübeck Interdisciplinary Platform for Genome Analytics (LIGA), Institutes of Neurogenetics & Integrative and Experimental Genomics, University of Lübeck, Lübeck, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.26651DOI Listing
May 2016

Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease.

Br J Clin Pharmacol 2016 08 19;82(2):461-72. Epub 2016 May 19.

Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, QC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bcp.12964DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972162PMC
August 2016

Cerebrospinal fluid biomarkers and clinical features in leucine-rich repeat kinase 2 (LRRK2) mutation carriers.

Mov Disord 2016 06 4;31(6):906-14. Epub 2016 Apr 4.

Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut de Neurociències Hospital Clínic, University of Barcelona, Catalonia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.26591DOI Listing
June 2016

Lithium Use in Older Adults is Associated with Increased Prescribing of Parkinson Medications.

Am J Geriatr Psychiatry 2016 Apr 10;24(4):301-9. Epub 2015 Dec 10.

University of Toronto, Toronto, Ontario, Canada; Division of Geriatric Psychiatry, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jagp.2015.11.004DOI Listing
April 2016

Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease.

JAMA Neurol 2016 05;73(5):535-41

Department of Veterans Affairs, Health Services Research and Development, Center for Clinical Management Research, Ann Arbor, Michigan8Geriatric Research, Education and Clinical Center, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan9Dep.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaneurol.2016.0031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5157923PMC
May 2016

Nonmotor features of Parkinson's disease subtypes.

Mov Disord 2016 08 10;31(8):1095-102. Epub 2016 Feb 10.

National Parkinson Foundation Centre of Excellence, Kings College Hospital and University Hospital Lewisham; and Kings College and Institute of Psychiatry, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mds.26510DOI Listing
August 2016